ASRS 2023: 27-Gauge vs 25-gauge vitrectomy for symptomatic vitreous opacities

News
Video

Our team spoke with Shawn Kavoussi, MD, at the 2023 ASRS meeting in Seattle, Washington about his research on using infrared video for vitreous opacities and comparing postoperative reduction in vitreous opacity scores using infrared video with the Heidelberg spectralis unit.

Our team spoke with Shawn Kavoussi, MD, at the 2023 ASRS meeting in Seattle, Washington about his research on using infrared video for vitreous opacities and comparing postoperative reduction in vitreous opacity scores using infrared video with the Heidelberg spectralis unit.

Video Transcript

Editor's note - This transcript has been edited for clarity.

Shawn Kavoussi, MD:

Dr Shawn Kavoussi from Houston, Texas. I'm excited to be here at ASRS in Seattle. My topic was using infrared video for vitreous opacities and comparing postoperative reduction in vitreous opacity scores using infrared video with the Heidelberg spectralis unit.

Patients were routine referrals with a chief complaint of symptomatic vitreous opacities. There were 38 eyes from 32 patients. The patients had preoperative infrared video scanning to quantify the vitreous opacities. And then the infrared video was used to grade the opacities using the macular vitreous opacity score that I presented last year, grades 1 through 4, which approximate how many quadrants of the macula are obscured by the vitreous opacities.

So what I found was that the pre-op macular vitreous opacities score in patients who elected to have vitrectomy for symptomatic floaters, the vast majority of cases were grade 2, which means that 26 to 50% of the macula was obscured. There were a few patients that were grade 3 and grade 4. Grade 3 means that 51 to 75% of the macular is obscured. Grade 4 means that greater than 75% of the macula is obscured, and many of the grade 4 patients had hemorrhagic PVDs, at the pre-op visit with either suspected or confirmed horseshoe tears at the pre-op screening. Half of the patients underwent 27 gauge vitrectomy on the Alcon constellation system. The other half underwent 25 gauge vitrectomy. All of the hemorrhagic PVD cases underwent 25 gauge vitrectomy on an urgent basis with endo laser.

About 1/3 of the patients were phakic at the pre-op screening but 80% of the hemorrhagic PVD patients were phakic. Average pre-op nvos was in the low 2s for the elective cases. Pre-op nvos was about 2.5, if you include the hemorrhagic PVDs. Altogether, 26 of the 38 eyes were novs grade 2 at pre-op. Post-operatively, 95% of the patients achieved nvos grade 0, meaning no opacities on the follow-up Heidelberg infrared video. There were 2 cases of slight residual grade 1 opacity post op, 1 in the 25 gauge group and 1 of the 27 gauge group. So there was no significant difference in post-operative vitreous opacity scores.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.